Wednesday, September 16, 2020 11:01:42 PM
Gee! I wonder why the FDA is not making Brilacidin go back and do some more animal trials? Could it be that Brilacidin has already proven that it’s “delivery mechanism works”...in actual humans? You know I do seem to recall that in the Phase 2 trial for ABSSSI, one thing that Brilacidin proved was that “its delivery mechanism works in a system that somewhat resembles a human system...vessels, membranes, pumps, etc.” Oh wait! Those patients in the ABSSSI trial didn’t just resemble a human system, they WERE human systems, hundreds of them in fact! And Brilacidin worked GREAT!
Lemoncat said,
You are still wrong and “Prurisol IS a shiny example of that.” The mice in the Prurisol trial were even genetically engineered to better reflect human tissue. But while Prurisol worked well for the mice, it did not work in humans.
In the case at hand, we already know from previous trials that Brilacidin’s “delivery mechanism works” in the actual human system. We also know that it kills the virus in human cells at rates approaching 100%. Do you really think that a few tests on animals means that Ab8 is somehow ahead of Brilacidin in the race to prove efficacy in humans? Sorry, but you are just sooo wrong...
Oh, and I know safety is not something you like to focus on, but remember; Brilacidin has been proven to be safe in humans with an SI Rating for Covid of >300. Ab8 has not been proven safe in humans and does it even have an SI Rating for anything? Oh well, one of those articles did mention that they had more animal testing to do before they could talk to the FDA about human testing.
"It is difficult to get a man to understand something, when his salary depends upon his not understanding it."
Upton Sinclair
Recent IPIX News
- Form 8-K - Current report • Edgar (US Regulatory) • 02/01/2024 01:30:25 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/05/2023 09:25:58 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/20/2023 09:05:44 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 11/15/2023 01:00:19 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2023 08:15:25 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 09/28/2023 01:00:08 PM
ECGI Holdings Announces LOI to Acquire Pacific Saddlery to Capitalize on $12.72 Billion Market Potential • ECGI • Jun 13, 2024 9:50 AM
Fifty 1 Labs, Inc. Announces Major Strategic Advancements and Shareholder Updates • CAFI • Jun 13, 2024 8:45 AM
Snakes & Lattes Opens Pop-Up Location at The Wellington Market in Toronto: A New Destination for Fun and Games - Thanks 'The Well', PepsiCo, Indie Pale House & All Sponsors & Partners for Their Commitment & Assistance Throughout The Process • FUNN • Jun 13, 2024 8:18 AM
HealthLynked Introduces Innovative Online Medical Record Request Form Using DocuSign • HLYK • Jun 12, 2024 8:00 AM
Ubiquitech Software Corp (OTC:UBQU) Posts $624,585 Quarterly Revenue - Largest Quarter Since 2018 • UBQU • Jun 11, 2024 10:13 AM
Element79 Gold Corp Files for OTCQB Uplisting, Provides Financial Update • ELEM • Jun 11, 2024 9:25 AM